The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Percutaneous interventional options for the treatment of tricuspid regurgitation

EuroIntervention 2016;12:Y107. DOI: 10.4244/EIJV12SYA28

1. Medical Clinic I, Städtische Klinken Neuss, Lukaskrankenhaus GmbH, Neuss, Germany; 2. St Thomas’ Hospital, London, United Kingdom
Tricuspid regurgitation (TR) can be differentiated as primary (mainly due to infective endocarditis), as secondary or functional (due to annular dilatation and leaflet tethering as a consequence of right ventricular dilatation and remodelling). Although functional TR is broadly underdiagnosed, it is associated with symptoms of right heart failure, reduced quality of life and poor outcome. As a stand-alone therapy, surgical repair for functional TR is rarely performed because it is associated with poor outcome owing to patient comorbidities. Moreover, although concomitant surgical tricuspid valve repair is frequently considered in patients with functional TR who require surgical repair of other valves ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article

Transcatheter interventions for tricuspid regurgitation: MitraClip